# A Study in Non-squamous Non Small Cell Lung Cancer in Asian Patients

> **NCT01020786** · PHASE4 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 109 (actual)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **DRUG:** Pemetrexed
- **DRUG:** Carboplatin

## Key facts

- **NCT ID:** NCT01020786
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2011-03
- **Final completion:** 2012-06
- **Target enrollment:** 109 (ACTUAL)
- **Last updated:** 2013-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01020786

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01020786, "A Study in Non-squamous Non Small Cell Lung Cancer in Asian Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01020786. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*